OMNIAB, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
OMNIAB, INC. (OABI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 6.37 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 330.00K shares, a 34.45% decline year-over-year.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 6.04M shares, a 66.05% increase year-over-year.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 41.50K shares, a 73.36% decline year-over-year.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 4.18M shares, a 25.75% increase from fiscal 2024.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 3.33M shares, a 26.86% decline from fiscal 2023.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 4.55M shares, a 22.26% decline from fiscal 2022.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 5.85M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 330.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 6.37M shares 10-Q · filed 2026-08-06 | 6.41M shares derived: sum of 3 quarters · filed 2026-08-06 | 6.41M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 6.04M shares 10-Q · filed 2026-05-07 | 6.08M shares derived: sum of 2 quarters · filed 2026-05-07 | 6.08M shares derived: sum of 3 quarters · filed 2026-05-07 | 6.59M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 41.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 41.50K shares derived: sum of 2 quarters · filed 2026-03-04 | 544.95K shares derived: sum of 3 quarters · filed 2026-03-04 | 4.18M shares 10-K · filed 2026-03-04 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | 503.45K shares derived: sum of 2 quarters · filed 2025-11-04 | 4.14M shares 10-Q · filed 2025-11-04 | 4.30M shares derived: sum of 4 quarters · filed 2025-11-04 |
| 2025-06-30 | 503.45K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 4.14M shares 10-Q · filed 2025-08-06 | 4.30M shares derived: sum of 3 quarters · filed 2025-08-06 | 4.33M shares derived: sum of 4 quarters · filed 2025-08-06 |
| 2025-03-31 | 3.64M shares 10-Q · filed 2025-05-08 | 3.79M shares derived: sum of 2 quarters · filed 2025-05-08 | 3.82M shares derived: sum of 3 quarters · filed 2025-05-08 | 4.14M shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 155.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | 184.60K shares derived: sum of 2 quarters · filed 2025-03-18 | 502.60K shares derived: sum of 3 quarters · filed 2025-03-18 | 3.33M shares 10-K · filed 2025-03-18 |
| 2024-09-30 | 28.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 346.80K shares derived: sum of 2 quarters · filed 2024-11-12 | 3.17M shares 10-Q · filed 2024-11-12 | 3.44M shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 318.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 3.14M shares 10-Q · filed 2024-08-08 | 3.41M shares derived: sum of 3 quarters · filed 2024-08-08 | 3.54M shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 2.82M shares 10-Q · filed 2024-05-09 | 3.09M shares derived: sum of 2 quarters · filed 2024-05-09 | 3.22M shares derived: sum of 3 quarters · filed 2024-05-09 | 6.29M shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 268.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | 397.55K shares derived: sum of 2 quarters · filed 2024-03-25 | 3.47M shares derived: sum of 3 quarters · filed 2024-03-25 | 4.55M shares 10-K · filed 2024-03-25 |
| 2023-09-30 | 128.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 3.20M shares derived: sum of 2 quarters · filed 2023-11-09 | 4.28M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 3.07M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 4.15M shares 10-Q · filed 2023-08-10 | ||
| 2023-03-31 | 1.08M shares 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | 5.85M shares 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |